Literature DB >> 23537684

Minimal change disease caused by exposure to mercury-containing skin lightening cream: a report of 4 cases.

Hon-Lok Tang1, Yuen-Fun Mak, Kwok-Hong Chu, William Lee, Samuel Kaâ Shun Fung, Thomas Yan-Keung Chan, Kwok-Lung Tong.   

Abstract

Mercury is a known cause of nephrotic syndrome and the underlying renal pathology in most of the reported cases was membranous nephropathy. We describe here 4 cases of minimal change disease following exposure to mercury-containing skin lightening cream for 2 - 6 months. The mercury content of the facial creams was very high (7,420 - 30,000 parts per million). All patients were female and presented with nephrotic syndrome and heavy proteinuria (8.35 - 20.69 g/d). The blood and urine mercury levels were 26 - 129 nmol/l and 316 - 2,521 nmol/d, respectively. Renal biopsy revealed minimal change disease (MCD) in all patients. The use of cosmetic cream was stopped and chelation therapy with D-penicillamine was given. Two patients were also given steroids. The time for blood mercury level to normalize was 1 - 7 months, whereas it took longer for urine mercury level to normalize (9 - 16 months). All patients had complete remission of proteinuria and the time to normalization of proteinuria was 1 - 9 months. Mercury-containing skin lightening cream is hazardous because skin absorption of mercury can cause minimal change disease. The public should be warned of the danger of using such products. In patients presenting with nephrotic syndrome, a detailed history should be taken, including the use of skin lightening cream. With regard to renal pathology, apart from membranous nephropathy, minimal change disease should be included as another pathological entity caused by mercury exposure or intoxication.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537684

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

1.  Mercury Contamination of Skin-whitening Creams in Phnom Penh, Cambodia.

Authors:  Thomas Murphy; Sothea Kim; Prean Chanra; Sereyrath Lim; Kenneth Wilson; Kim N Irvine; Darell G Slotton; Lori Allen
Journal:  J Health Pollut       Date:  2015-12-21

2.  Unveiling the Features of Mercury-Associated Minimal Change Disease: Comparison with Primary Minimal Change Disease.

Authors:  Ai-Bo Qin; Xiao-Juan Yu; Su-Xia Wang; Fu-de Zhou; Ming-Hui Zhao
Journal:  Kidney Dis (Basel)       Date:  2020-09-29

3.  Mercury-associated glomerulonephritis: a retrospective study of 35 cases in a single Chinese center.

Authors:  Ai-Bo Qin; Tao Su; Su-Xia Wang; Fan Zhang; Fu-de Zhou; Ming-Hui Zhao
Journal:  BMC Nephrol       Date:  2019-06-20       Impact factor: 2.388

4.  Epidemiology, clinical presentation, treatment, and follow-up of chronic mercury poisoning in China: a retrospective analysis.

Authors:  Sun Yawei; Long Jianhai; Zhao Junxiu; Peng Xiaobo; Qiu Zewu
Journal:  BMC Pharmacol Toxicol       Date:  2021-05-03       Impact factor: 2.483

5.  Mercury Toxicity and Contamination of Households from the Use of Skin Creams Adulterated with Mercurous Chloride (Calomel).

Authors:  Lori Copan; Jeff Fowles; Tracy Barreau; Nancy McGee
Journal:  Int J Environ Res Public Health       Date:  2015-09-02       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.